Lupus Research Alliance Nov 22 2024 Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance (LRA), today announced a pioneering funding mechanism to address one of the most common questions about lupus clinical care and management. The IDEAL ( I nvestigate D i e tary A pproaches for L upus) Initiative was established to fund pilot clinical studies assessing the impact of diet intervention on the lived experience of lupus and to address the void of well-controlled studies in